Outbreak of hepatitis C virus infection in an outpatient clinic

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 7, 2005, Pages 1087-1093

  Ishikawa, Takashi ^a   Fukushima, Yasushi ^a   Shiobara, Yujiro ^b   Kishimoto, Tsuyoshi ^c   Tanno, Sakiko ^c   Shoji, Ikuo ^d   Suzuki, Tetsuro ^d   Matsui, Tamano ^d   Shimada, Yasushi ^d   Ohyama, Takaaki ^d   Nagai, Ryozo ^a   Miyamura, Tatsuo ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b Fukaya Red Cross Hospital   (Japan)

^c SAITAMA INSTITUTE OF PUBLIC HEALTH   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Hepatitis C virus; Nosocomial infection; Outbreak; Outpatient clinic

Indexed keywords

ADULT; AGED; ANAMNESIS; ASPIRATION; CASE CONTROL STUDY; CHOLANGIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; HEPATITIS C; HOSPITAL INFECTION; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; INFUSION; INJECTION; INTRAVENOUS PYELOGRAPHY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOBLOTTING; JAPAN; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL;

EID: 21844451417     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03883.x     Document Type: Review

References (33)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N. Engl. J. Med. 2001; 345: 41-52.
2. Cohen J. The scientific challenge of hepatitis C. Science 1999; 285: 26-30.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999; 340: 745-50.
4. Japan Red Cross Non-A, Non-B Hepatitis Reseach Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of posttransfusion hepatitis. Lancet 1991; 338: 1040-1.
5. Sasaki F, Tanaka J, Moriya T et al. Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan. J. Epidemiol 1996; 6: 198-203.
6. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002; 62 (Suppl. 1): 8-17.
7. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N. Engl. J. Med. 1996; 334: 1685-90.
8. Ohnuma H, Tanaka T, Yoshikawa A et al. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV. Microbiol. Immunol. 2001; 45: 667-72.
9. Esteban JI, Gomez J, Martell M et al. Transmission of hepatitis C virus by a cardiac surgeon. N. Engl. J. Med. 1996; 334: 555-60.
10. Ross RS, Viazov S, Gross T, Hofmann F, Seipp HM, Roggendorf M. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N. Engl. J. Med. 2000; 343: 1851-4.
11. Allander T, Gruber A, Naghavi M et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345: 603-7.
12. Widell A, Christensson B, Wiebe T et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann. Intern. Med. 1999; 130: 130-4.
13. Bronowicki JP, Venard V, Botte C et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N. Engl. J. Med. 1997; 337: 237-40.
14. Allander T, Medin C, Jacobson SH, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J. Med. Virol. 1994; 43: 415-19.
15. Halfon P, Roubicek C, Gerolami V et al. Use of phylogenetic analysis of hepatitis C virus (HCV) hypervariable region 1 sequences to trace an outbreak of HCV in an autodialysis unit. J. Clin. Microbiol. 2002; 40: 1541-5.
16. Larghi A, Zuin M, Crosignani A et al. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 2002; 36: 993-1000.
17. Ou CY, Ciesielski CA, Myers G et al. Molecular epidemiology of HIV transmission in a dental practice. Science 1992; 256: 1165-71.
18. Katzenstein TL, Jorgensen LB, Permin H et al. Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. AIDS 1999; 13: 1737-44.
19. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
20. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16: 619-24.
21. Brown A. Methods in evolutionary analysis of viral sequences. In: Morse SSE, ed. The Evolutionary Biology of Viruses. New York: Raven Press, 1994; 75-84.
22. Suzuki K, Mizokami M, Lau JY et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J. Infect. Dis. 1994; 170: 1575-8.
23. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26: 15S-20S.
24. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26: 62S-65S.
25. Frank C, Mohamed MK, Strickland GT et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-91.
26. Hayashi J, Kishihara Y, Yamaji K et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am. J. Gastroenterol. 1995; 90: 794-9.
27. Guadagnino V, Stroffolini T, Rapicetta M et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26: 1006-11.
28. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 1999; 341: 556-62.
29. Vogt M, Lang T, Frosner G et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N. Engl. J. Med. 1999; 341: 866-70.
30. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N. Engl. J. Med. 1999; 340: 1228-33.
31. Gerlach JT, Diepolder HM, Zachoval R et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125: 80-8.
32. Jaeckel E, Cornberg M, Wedemeyer H et al. Treatment of acute hepatitis C with interferon alfa-2b. N. Engl. J. Med. 2001; 345: 1452-7.
33. McHutchison JG, Gordon SC, Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med. 1998; 339: 1485-92.